WO2011155727A3 - 살모넬라 콜레라수이스 또는 살모넬라 두블린 감염을 방지 및 처치하는 방법 - Google Patents

살모넬라 콜레라수이스 또는 살모넬라 두블린 감염을 방지 및 처치하는 방법 Download PDF

Info

Publication number
WO2011155727A3
WO2011155727A3 PCT/KR2011/004066 KR2011004066W WO2011155727A3 WO 2011155727 A3 WO2011155727 A3 WO 2011155727A3 KR 2011004066 W KR2011004066 W KR 2011004066W WO 2011155727 A3 WO2011155727 A3 WO 2011155727A3
Authority
WO
WIPO (PCT)
Prior art keywords
salmonella
bacteria
infection caused
dublin
choleraesuis
Prior art date
Application number
PCT/KR2011/004066
Other languages
English (en)
French (fr)
Other versions
WO2011155727A2 (ko
Inventor
윤성준
전수연
백형록
강상현
Original Assignee
주식회사 인트론바이오테크놀로지
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 인트론바이오테크놀로지 filed Critical 주식회사 인트론바이오테크놀로지
Publication of WO2011155727A2 publication Critical patent/WO2011155727A2/ko
Publication of WO2011155727A3 publication Critical patent/WO2011155727A3/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10211—Podoviridae
    • C12N2795/10232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

본 발명은 살모넬라 콜레라수이스(Salmonella Choleraesuis) 균 및 살모넬라 두블린(Salmonella Dublin) 균의 감염을 방지하는데 이용될 수 있고, 또한 살모넬라 콜레라수이스 균 및 살모넬라 두블린 균의 감염 질환을 처치할 수 있는 방법에 관한 것으로, 더욱 상세하게는 서열번호 1로 표시되는 유전체를 갖는 것을 특징으로 하는 박테리오파지(Bacteriophage), 서열번호 2 내지 서열번호 22의 부분 유전자 서열로 표시되는 유전체를 갖는 것을 특징으로 하는 박테리오파지, 또는 상기 두 박테리오파지의 혼합물을 유효성분으로 포함하는 조성물, 및 이 조성물을 이용하여 살모넬라 콜레라수이스 균이나 살모넬라 두블린 균의 감염을 방지하거나 살모넬라 콜레라수이스 균 또는 살모넬라 두블린 균의 감염 질환을 처치하는 방법에 관한 것이다.
PCT/KR2011/004066 2010-06-09 2011-06-03 살모넬라 콜레라수이스 또는 살모넬라 두블린 감염을 방지 및 처치하는 방법 WO2011155727A2 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020100054156A KR101260655B1 (ko) 2010-06-09 2010-06-09 살모넬라 콜레라수이스 또는 살모넬라 두블린 감염을 방지 및 처치하는 방법
KR10-2010-0054156 2010-06-09

Publications (2)

Publication Number Publication Date
WO2011155727A2 WO2011155727A2 (ko) 2011-12-15
WO2011155727A3 true WO2011155727A3 (ko) 2012-04-19

Family

ID=45098502

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/004066 WO2011155727A2 (ko) 2010-06-09 2011-06-03 살모넬라 콜레라수이스 또는 살모넬라 두블린 감염을 방지 및 처치하는 방법

Country Status (2)

Country Link
KR (1) KR101260655B1 (ko)
WO (1) WO2011155727A2 (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102016919B1 (ko) * 2016-12-23 2019-09-02 주식회사 옵티팜 신규한 살모넬라균 특이 박테리오파지 sc1 및 이를 포함하는 항균 조성물
KR102093241B1 (ko) 2018-09-14 2020-03-25 경북대학교 산학협력단 살모넬라 엔테리티디스균의 증식을 억제하는 신규 박테리오파지 및 이의 용도
KR102093238B1 (ko) 2018-09-14 2020-05-22 경북대학교 산학협력단 살모넬라 타이피뮤리움의 증식을 억제하는 신규 박테리오파지 및 이의 용도
KR102341100B1 (ko) * 2019-06-25 2021-12-21 주식회사 옵티팜 신규한 살모넬라균 특이 박테리오파지 ss1 및 이를 포함하는 항균 조성물
KR102592424B1 (ko) * 2021-06-04 2023-10-25 경북대학교 산학협력단 병원성 대장균, 살모넬라 또는 시겔라에 대해 사멸능을 갖는 박테리오파지 및 이를 함유하는 항균 조성물

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070054357A1 (en) * 2005-09-06 2007-03-08 Pasternack Gary R Identification of useful bacteriophage
KR20090030385A (ko) * 2007-09-20 2009-03-25 주식회사 인트론바이오테크놀로지 살모넬라 엔테리티디스 감염 박테리오파지로부터 선별된살모넬라 특이적 사멸능을 갖는 신규한 박테리오파지
KR20090030386A (ko) * 2007-09-20 2009-03-25 주식회사 인트론바이오테크놀로지 살모넬라 갈리나룸 감염 박테리오파지로부터 선별된살모넬라 특이적 사멸능을 갖는 신규한 박테리오파지
US20100135962A1 (en) * 2008-12-02 2010-06-03 Cj Cheiljedang Corporation Novel Bacteriophage and Antibacterial Composition Comprising the Same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070054357A1 (en) * 2005-09-06 2007-03-08 Pasternack Gary R Identification of useful bacteriophage
KR20090030385A (ko) * 2007-09-20 2009-03-25 주식회사 인트론바이오테크놀로지 살모넬라 엔테리티디스 감염 박테리오파지로부터 선별된살모넬라 특이적 사멸능을 갖는 신규한 박테리오파지
KR20090030386A (ko) * 2007-09-20 2009-03-25 주식회사 인트론바이오테크놀로지 살모넬라 갈리나룸 감염 박테리오파지로부터 선별된살모넬라 특이적 사멸능을 갖는 신규한 박테리오파지
US20100135962A1 (en) * 2008-12-02 2010-06-03 Cj Cheiljedang Corporation Novel Bacteriophage and Antibacterial Composition Comprising the Same

Also Published As

Publication number Publication date
WO2011155727A2 (ko) 2011-12-15
KR20110134554A (ko) 2011-12-15
KR101260655B1 (ko) 2013-05-10

Similar Documents

Publication Publication Date Title
MX2017008561A (es) Novedoso bacteriófago clo-pep-1 de clostridium perfringens y su uso para inhibir la proliferación de clostridium perfringens.
PH12017500852A1 (en) Combination therapy for treatment of resistant bacterial infections
EA201301320A1 (ru) 4-арил-n-фенил-1,3,5-триазин-2-амины, которые содержат сульфоксиминную группу
MY182771A (en) Viral replication inhibitors
MX2019002978A (es) Composiciones que comprenden una bacteria no patogena y metodos para proteger plantas y animales anfitriones contra enfermedades micoticas, bacterianas y virales.
SG178952A1 (en) Chemical compounds
WO2010057101A3 (en) Compounds useful as hiv blockers
BR112012019762A2 (pt) composto, composição, e, método para tratar uma doença.
NZ708928A (en) Mannose derivatives for treating bacterial infections
WO2016183532A8 (en) Bacteria engineered to treat a disease or disorder
WO2012009715A3 (en) Novel cyclosporin derivatives for the treatment and prevention of a viral infection
MX2017008562A (es) Novedoso bacteriófago de e. coli enteroinvasiva esc-cop-4 y su uso para inhibir la proliferación de e. coli enteroinvasiva.
WO2011155727A3 (ko) 살모넬라 콜레라수이스 또는 살모넬라 두블린 감염을 방지 및 처치하는 방법
WO2012006149A3 (en) Analogs of c5a and methods of using same
NZ594019A (en) Novel antibacterial agents for the treatment of gram positive infections
MX2013012233A (es) 4-aril-n-fenil-1,3,5-triazin-2-aminas sustituidas.
EP4268897A3 (en) Minocycline compounds for biodefense
PH12016502001A1 (en) Novel bacteriophage and composition comprising same
UA112551C2 (uk) Штам бактеріофага та його застосування
MX2014010655A (es) Peptidos antimicrobianos.
WO2012017434A3 (en) Guanine nucleotide derivatives for treating bacterial infections
WO2010052575A3 (en) Ngna compositions and methods of use
WO2012078519A3 (en) 3-acylidene-2-oxoindole derivatives for inhibition of transglutaminase 2
WO2012116254A3 (en) Chrysophaentin analogs that inhibit ftsz protein
EA037143B9 (ru) Композиция, содержащая нуклеиновые кислоты паразитических, патогенных или инвазивных биологических систем для ингибирования и/или контроля роста указанных систем, и способ ее получения

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11792638

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11792638

Country of ref document: EP

Kind code of ref document: A2